All News

Patients most often blame forgetfulness for not getting a second shot so reminders are key; just don't rely on a message via a patient portal to reach them.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Will desire to return to “normal” life propel patients to get a COVID-19 vaccine? What do they think about efforts to contain transmission? Answers and more insights here.

Director of the Brigham and Women's Diabetes Program Marie McDonnell, MD, talked with our editor about 2020 studies on SGLT-2 inhibitors, insulin icodec, and more.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Vaccines from both companies were significantly effective against COVID-19 and show promise against variants from the UK and South Africa.

In a phase 2/3 study, nearly half of rimegepant-treated patients demonstrated ≥50% reduction in the number of moderate-to-severe migraine days per month

US levels of SARS-CoV-2 circulation, associated illnesses, and deaths have been decreasing, but rising reporting delays due to holidays warrant caution.

The FDA approved vericiguat to reduce the risk of CV death and rehospitalization for HF in HF patients after hospital discharge or after outpatient treatment with IV diuretics.

In episode 6 of Primary Viewpoints, physician mental health expert Michael Myers, MD, discusses the state of physician mental health during the COVID-19 pandemic.

The COVID-19 pandemic, says Dr Michael Myers, is an unprecedented environment for practicing medicine and for practitioners to effectively process daily experience.

Availability of the COVID-19 vaccine cannot come fast enough for many large US cities, based on the share in each of the most vulnerable populations.

Global confirmed cases of COVID-19 have surpassed 100 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Compared to medication and lifestyle changes, metabolic surgery is more effective in the long-term control of severe T2D, a new study found.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Physical activity cannot compensate adequately for the negative impact of excess body weight on cardiometabolic health.

Merck announced today that it will halt development of its COVID-19 vaccine candidates, citing inadequate immune responses to the vaccines.

Cabotegravir and rilpivirine, injectable formulation is administered once-weekly, reducing treatment days for adults with HIV from 365 to 12.